Misplaced Pages

This is an old revision of this page, as edited by Boghog (talk | contribs) at 16:59, 2 March 2021 (+ cite). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article provides insufficient context for those unfamiliar with the subject. Please help improve the article by providing more context for the reader. (April 2014) (Learn how and when to remove this message) This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Rociverine" – news · newspapers · books · scholar · JSTOR (February 2009) (Learn how and when to remove this message) (Learn how and when to remove this message)

Rociverine

Clinical data
Other names	(1S)-1-(diethylamino)propan-2-yl 1-hydroxybi(cyclohexane)-2-carboxylate
AHFS/Drugs.com	International Drug Names
ATC code	A03AA06 (WHO)
Identifiers
IUPAC name 2-(diethylamino)-1-methylethyl (1S)-1-hydroxy-1,1'-bi(cyclohexyl)-2-carboxylate
CAS Number	53716-44-2
PubChem CID	68705
UNII	VI08KS44V0
CompTox Dashboard (EPA)	DTXSID501023860
ECHA InfoCard	100.053.356
Chemical and physical data
Formula	C20H37NO3
Molar mass	339.520 g·mol
(verify)

Rociverine is an antimuscarinic drug.

References

1. Toson G, Schiantarelli P, Murmann W (1978). "Rociverine, a new antispasmodic agent with balanced neurotropic and myotropic activity". Arzneimittel-Forschung. 28 (7): 1130–42. PMID 582702.

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Articles lacking sources from February 2009
• Tertiary alcohols
• Amines
• Carboxylate esters
• Muscarinic antagonists
• Cyclohexanes
• Gastrointestinal system drug stubs